ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

Sen. Feinstein To Introduce New National Cancer Act.

February 22, 2002

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005